Variables | All Patients (n = 2262) | Follow-up Patients (n = 1639) | With MACEs (n = 161) |
---|---|---|---|
Cardiovascular risk factors | |||
 Age | 60.04 ± 10.73 | 60.57 ± 10.81 | 59.45 ± 10.65 |
 Gender, (n)men% | 1675 (74.05%) | 1201 (73.28%) | 113 (70.19%)* |
 BMI | 24.37 ± 4.08 | 24.34 ± 4.30 | 23.76 ± 3.28 |
 Hypertension, n (%) | 1301 (57.51%) | 945 (57.66%) | 101 (62.73%)# |
 hyperlipidemia, n (%) | 149 (6.59%) | 99 (6.04%) | 10 (6.21%) |
 Diabetes, n (%) | 425 (18.79%) | 317 (19.34%) | 47 (29.19%)# |
 Current/ex-smoker, n (%) | 1149 (50.79%) | 818 (49.91%) | 85 (52.79%)* |
 Alcohol consumption (units per week), n (%) | 695 (30.73%) | 503 (30.69%) | 45 (27.95%)* |
 Previous myocardial infarction, n (%) | 235 (10.39%) | 152 (9.27%) | 18 (11.18%)* |
 Heart failure, n (%) | 35 (1.55%) | 25 (1.52%) | 5 (3.11%)* |
 History of cerebrovascular disease, n (%) | 157 (6.94%) | 117 (7.13%) | 14 (8.69%)* |
Biomarkers | |||
 TC (mmol/L) | 4.33 ± 1.74 | 4.33 ± 1.66 | 4.31 ± 1.56 |
 HDL-C (mmol/L) | 1.07 ± 0.55 | 1.06 ± 0.47 | 1.09 ± 0.78 |
 LDL-C (mmol/L) | 2.50 ± 0.95 | 2.49 ± 0.93 | 2.52 ± 0.92* |
 TG (mmol/L) | 1.89 ± 1.63 | 1.89 ± 1.56 | 1.84 ± 1.32 |
 ApoA1(g/L) | 1.18 ± 0.48 | 1.20 ± 0.55 | 1.15 ± 0.32 |
 ApoB(g/L) | 0.89 ± 0.49 | 0.90 ± 0.53 | 1.02 ± 0.79* |
Blood pressure (mm Hg) | |||
 Systolic | 140 ± 14.17 | 140 ± 15.23 | 141 ± 15.78 |
 Diastolic | 80 ± 13.19 | 80 ± 13.25 | 84 ± 12.86* |
Coronary angiography | |||
 1-vessel disease, n (%) | 683 (30.19%) | 497 (30.32) | 34 (21.12%)# |
 2-vessel disease, n (%) | 712 (31.47%) | 515 (31.42) | 42 (26.08%)# |
 3-vessel disease, n (%) | 867 (38.32%) | 626 (38.19) | 85 (52.80%)# |